Insider Transactions in Q2 2021 at Vincerx Pharma, Inc. (VINC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Sooin Hwang Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.13%
|
$6,000
$12.66 P/Share
|
|
Jun 30
2021
|
Laura I. Bushnell |
BUY
Open market or private purchase
|
Direct |
1,800
+50.0%
|
$21,600
$12.94 P/Share
|
|
Jun 30
2021
|
Christopher P. Lowe Director |
BUY
Open market or private purchase
|
Direct |
3,600
+26.47%
|
$43,200
$12.66 P/Share
|
|
Jun 29
2021
|
Andrew I Mc Donald Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$240,000
$12.38 P/Share
|
|
Jun 29
2021
|
John H. Lee |
BUY
Open market or private purchase
|
Direct |
799
+50.0%
|
$9,588
$12.71 P/Share
|
|
Jun 29
2021
|
Tom C Thomas |
BUY
Open market or private purchase
|
Indirect |
2,000
+50.0%
|
$24,000
$12.58 P/Share
|
|
Jun 29
2021
|
Christopher P. Lowe Director |
BUY
Open market or private purchase
|
Direct |
6,400
+50.0%
|
$76,800
$12.59 P/Share
|
|
Jun 29
2021
|
Alexander A. Seelenberger Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,950
+50.0%
|
$95,400
$12.61 P/Share
|
|
Jun 29
2021
|
Ahmed Md Hamdy Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
7,830
+50.0%
|
$93,960
$12.77 P/Share
|